Validity of one-time assessments for identifying prodromal Alzheimer's disease in adults with Down syndrome

一次性评估对识别唐氏综合征成人阿尔茨海默病前驱期的有效性

阅读:1

Abstract

INTRODUCTION: New Alzheimer's disease (AD) treatments have created an urgent need for accurate early diagnosis of high-risk adults with Down syndrome (DS), distinguishing prodromal DS-AD symptoms from lifelong cognitive impairments. Often, clinicians will need to evaluate dementia status during a single assessment, and here we describe empirically supported methods effective under such circumstances. METHODS: Archived data collected between 1987 and 2017 included longitudinal findings for 144 individuals maintaining cognitive stability and 126 developing prodromal DS-AD. Response operating characteristic analyses compared groups, defined by the presence/absence of prodromal DS-AD, for a single assessment. RESULTS: Groups differed on all measures without adjusting for developmental history, 0.717 < areas under the curve < 0.859, Ps < 0.0001. The balance between sensitivity and specificity improved slightly when developmental histories were considered. DISCUSSION: The present study demonstrated that one-time assessments can inform clinical judgments when diagnosing adults at risk for DS-AD. Knowledge of developmental history is valuable but non-essential. HIGHLIGHTS: Non-overlapping distributions were observed for preclinical and prodromal Alzheimer's disease (AD) groups.Receiver operating characteristic area under the curve analyses were in the acceptable to excellent range for all measures.Performance was sensitive to both the severity of intellectual disability and the stage of Down syndrome-AD progression.Episodic memory tests were sensitive to the transition from preclinical to prodromal AD.Performance results at a single time point can inform dementia status decisions.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。